Coforge Limited (COFORGE)
Transcript of the Earnings Conference Call
AI summary
- Q1FY27 revenue $592.2mn, up 49% YoY including Encora; organic growth strong
- EBIT margin 16.0% consolidated; standalone Coforge at 16.7%; Encora EBIT margin 19.1%
- Order intake $691mn organic; 12-month executable order book $2.23bn, +44.2% YoY
- Headcount 46,228; net addition 10,451 including 9,256 from Encora; attrition 10.4%
- FY27 outlook: consolidated EBIT margin 15.5%+, standalone 16.5-17%, EBITDA margin 20.5-21%
- Free cash flow $52.9mn in Q1; FCF to PAT conversion 95.3%; FY27 target 100%+
- AI-led services contribute 86% of revenue; $58mn invested in AI innovation in FY26
- Large deal pipeline strong; Q2 deals closed early; growth expected to remain robust
- Integration of Encora ahead of plan with 40% reduction in G&A costs
- Management confident of industry-leading revenue growth and margin expansion in FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 COFORGE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add COFORGE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Coforge Limited
Important.
The summary above is generated automatically from Coforge Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.